 The Sean M. Healey AMG Center for ALS at Mass General received approval from the FDA and the Mass General Brigham Institutional Review Board to add SLS-005 trehalose injection, 90.5 mgML for intravenous infusion as an additional regimen in the HEALEY ALS Platform Trial. 